(Q40250027)

18 September 2017

Magnesium Sulphate for Eclampsia and Fetal Neuroprotection: A Comparative Analysis of Protocols Across Canadian Tertiary Perinatal Centres (English)

1 reference

18 September 2017

0 references

0 references

3

Peter von Dadelszen

1 reference

18 September 2017

7

Laura A Magee

1 reference

18 September 2017

Dane A. De Silva

1

0 references

Laura A Magee

7

object named as

Laura A. Magee

0 references

Anne Synnes

5

object named as

Anne R Synnes

1 reference

18 September 2017

5

Anne R. Synnes

0 references

Diane Sawchuck

2

object named as

Diane Sawchuck

1 reference

18 September 2017

4

Melanie Basso

1 reference

18 September 2017

1

Dane A De Silva

1 reference

18 September 2017

Robert M Liston

6

1 reference

18 September 2017

Robert M. Liston

6

0 references

publication date

1 November 2015

1 reference

Journal of Obstetrics and Gynaecology Canada

18 September 2017

November 2015

0 references

published in

1 reference

18 September 2017

37

1 reference

18 September 2017

975-987

1 reference

18 September 2017

11

1 reference

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

The Canadian Perinatal Network: a national network focused on threatened preterm birth at 22 to 28 weeks' gestation.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Obstetrical accidents involving intravenous magnesium sulfate: recommendations to promote patient safety.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

An updated overview of clinical guidelines for the management of non-specific low back pain in primary care.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930047-0

7 January 2021

10.1016/S1701-2163(16)30047-0

Identifiers

DOI

0 references

1 reference